Novo Nordisk And Eli Lilly Will Mint Money Soon
Elon Musk revealed that he achieved his "fit, ripped, and healthy" physique through fasting and the weight-loss drug Wegovy. Wegovy (semaglutide), will sell $3bn-4bn of it in America alone this year. The firm plans to launch the drug in many more countries in the coming months. Its share price is up by 40% over the past year and has doubled over the past two. Eli Lilly, another pharmaceutical firm, hopes to start selling a similar treatment for obesity, called Mounjaro (tirzepatide), as early as this summer. Like Comment Share